Compounds > cytarabine

cytarabine and Hemoglobinuria, Paroxysmal

cytarabine has been researched along with Hemoglobinuria, Paroxysmal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, Y; Fu, R; Li, L; Liu, C; Liu, H; Liu, Z; Shao, Z; Wang, H; Zhao, X1
Füreder, W; Gleixner, K; Grünberger, B; Hoermann, G; Kornauth, C; Schwarzinger, I; Sperr, WR; Thalhammer, R; Valent, P1
Bai, J; Cao, YR; Cui, ZZ; Fu, R; He, GS; Jia, HR; Liu, H; Qin, TJ; Shao, ZH; Shi, J; Sun, J; Tu, HF; Wu, YH; Yang, TY; Zhao, MF1
Chosa, M; Kawano, F; Matsuoka, M; Oyamada, N; Takatsuki, K1

Other Studies

4 other study(ies) available for cytarabine and Hemoglobinuria, Paroxysmal

ArticleYear
Clinical observation of low-dose combination chemotherapy in refractory/recurrent paroxysmal nocturnal hemoglobinuria patients: A single-center retrospective analysis.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:2

    Topics: Adult; Aged; Cytarabine; Daunorubicin; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Hemoglobinuria, Paroxysmal; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Rate

2022
Major response of PNH to an AML chemotherapy protocol.
    Annals of hematology, 2018, Volume: 97, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Cytarabine; Daunorubicin; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction

2018
[Preliminary study of DA or HA regimen chemotherapy for the treatment of refractory and relapsed paroxysmal nocturnal hemoglobinuria].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2004, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Glycosylphosphatidylinositols; Harringtonines; Hemoglobinuria, Paroxysmal; Humans; Male

2004
Paroxysmal nocturnal hemoglobinuria: termination in acute monocytic leukemia and reappearance after chemotherapy with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) and vincristine.
    Japanese journal of clinical oncology, 1987, Volume: 17, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Female; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Monocytic, Acute; Recurrence; Time Factors; Vincristine

1987